Products

Primary tabs

Export products to Excel

Displaying 1 - 10 of 10
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Pre-clinical
Partner: Viramal Limited
Alternative Name: FC-Patch low, Lisvy®
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Regulatory
Alternative Name: Twirla, AG200-15, Levonorgestrel + ethinyl estradiol patch
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase III
Alternative Name: Levonorgestrel (LNG)-only patch; AG890
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase I
Alternative Name: MENT Transdermal Gel
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase I
Alternative Name: Nestorone + Testosterone Gel
Development Status: Active Development
Target: Male
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase II
Alternative Name: Nestorone (NES) Metered Dose Transdermal System® (MDTS®)
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase I
Alternative Name: Nestorone (NES) + Estradiol (E2) Transdermal Gel
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase II
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Regulatory
Partner: Actavis
Alternative Name: “Mini-pill” cream
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Pre-clinical
Partner: Viramal Limited
Export to Excel